Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Imaging Guidance for Watchman Device Implant in Atrial Fibrillation

Tests intracardiac echocardiography to guide placement of the Watchman device in adults with atrial fibrillation.

Plain-language title generated from the registry record
Registry title: Intracardiac Echocardiography Guided Watchman Device Implant

Key facts

Where
Cleveland, United StatesSee the site

Where in United States

  • Cleveland ClinicCleveland, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
The Cleveland Clinic
Trial code
NCT06007872
Record updated
9 November 2026
Original description
This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device correctly and effectively.Read full original descriptionShow less

Feasibility: Intracardiac Echocardiography Guided Watchman Device Implant

This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device correctly and effectively.

Inclusion: All patients who meet guideline established criteria for commercially available Watchman device implant and not enrolled in an active clinical trial.

Exclusion: Patients in whom a procedural TEE cannot be performed and an ICE only implant is needed; Patients receiving a concomitant ablation procedure; Patients with prior incomplete surgical or percutaneous left atrial appendage ligation/exclusion procedures; Patients in whom the delivery of trans-septal equipment is anticipated to be difficult (e.g. patent foramen ovale (PFO) or atrial septal defect (ASD) closure devices in place).

ClinicalTrials.gov NCT06007872